Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

9.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
9.6K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

7.2K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Open forum infectious diseases·2026
Same author

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.

American journal of hematology·2025
Same author

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.

American journal of hematology·2024
Same author

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

DLBCL: who is high risk and how should treatment be optimized?

Blood·2023

Related Experiment Video

Updated: Apr 27, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

10.6K

Primary mediastinal large B-cell lymphoma.

Anna Dabrowska-Iwanicka1, Jan A Walewski

  • 1Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute and Oncology Centre, 5 WK Roentgen Str, 02-781, Warszawa, Poland, adab@coi.waw.pl.

Current Hematologic Malignancy Reports
|June 22, 2014
PubMed
Summary

Primary mediastinal B-cell lymphoma (PMBCL) is a rare cancer in young adults. Adding rituximab to chemotherapy improves outcomes, but optimal treatment and radiotherapy roles require further study for personalized strategies.

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

1.0K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

14.2K

Related Experiment Videos

Last Updated: Apr 27, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

10.6K
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

1.0K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

14.2K

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Primary mediastinal B-cell lymphoma (PMBCL) is a rare subtype of lymphoma primarily affecting young adults.
  • PMBCL shares molecular and clinical similarities with classical Hodgkin lymphoma.
  • The optimal chemotherapy regimen for PMBCL remains undetermined.

Purpose of the Study:

  • To review current treatment strategies for PMBCL.
  • To evaluate the impact of rituximab and consolidation radiotherapy on patient outcomes.
  • To identify future directions for risk-adapted and targeted therapies in PMBCL.

Main Methods:

  • Review of recent retrospective analyses on PMBCL treatment.
  • Discussion of ongoing prospective studies evaluating consolidation radiotherapy.
  • Analysis of molecular mechanisms underlying PMBCL pathogenesis.

Main Results:

  • The addition of rituximab to anthracycline-based chemotherapy has improved response rates and survival in PMBCL.
  • R-CHOP is commonly used, but the necessity of intensified regimens and consolidation radiotherapy is under investigation.
  • Emerging data suggest that risk-adapted strategies can optimize treatment effectiveness.

Conclusions:

  • Rituximab-containing chemotherapy represents a significant advancement in PMBCL treatment.
  • Further research is needed to clarify the role of consolidation radiotherapy and intensified regimens for risk stratification.
  • Understanding PMBCL molecular pathways opens avenues for novel targeted therapies.